Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study

Our findings suggest that the measurement of circulating activin A may support the histological classification of MPM and at the same time help to identify epithelioid MPM patients with poor prognosis.